12 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27133481	30	Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.	Merck
26935940	23	Emerging targets and new small molecule therapies in Parkinson's disease treatment.	School of Medicine of University of Electronic Science and Technology of China
25815153	47	Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT).	Merck Research Laboratories
24847974	13	A fragment-based approach to identifying S-adenosyl-l-methionine -competitive inhibitors of catechol O-methyl transferase (COMT).	Takeda California
16335931	14	Synthesis and biological evaluation of a novel series of"ortho-nitrated" inhibitors of catechol-O-methyltransferase.	Department of Research & Development
11806720	6	Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase.	Department of Research & Development
32299731	56	Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.	North-West University
27463695	34	Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.	University of Porto
7069705	5	Catechol O-methyltransferase. 12. Affinity labeling the active site with the oxidation products of 5,6-dihydroxyindole.	TBA
30272964	57	Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase.	Lieber Institute For Brain Development
2704029	44	Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors.	Orion